Ming Tsao

Ming Tsao

University of Toronto

H-index: 146

North America-Canada

About Ming Tsao

Ming Tsao, With an exceptional h-index of 146 and a recent h-index of 89 (since 2020), a distinguished researcher at University of Toronto, specializes in the field of molecular pathology, lung cancer, translational research, pancreatic cancer.

His recent articles reflect a diverse array of research interests and contributions to the field:

Genomic staging of multifocal lung squamous cell carcinomas is independent of the comprehensive morphologic assessment

Author Correction: The evolutionary history of 2,658 cancers (Nature,(2020), 578, 7793,(122-128), 10.1038/s41586-019-1907-7)

CANTRK: a Canadian ring study to optimize detection of NTRK gene fusions by next-generation RNA sequencing

Wide‐field Stokes polarimetric microscopy for second harmonic generation imaging

Longitudinal plasma ctDNA testing in resected early-stage NSCLC

Historical development of EGFR-targeted therapy

β-catenin mediates growth defects induced my centrosome loss in APC mutant colorectal cancer independently of p53

ctDNA dynamics in early stage node negative lung cancers

Ming Tsao Information

University

University of Toronto

Position

Professor of Laboratory Medicine and Pathobiology Senior Scientist and Consultant Pathologist Princess

Citations(all)

108018

Citations(since 2020)

47104

Cited By

80048

hIndex(all)

146

hIndex(since 2020)

89

i10Index(all)

598

i10Index(since 2020)

434

Email

University Profile Page

University of Toronto

Ming Tsao Skills & Research Interests

molecular pathology

lung cancer

translational research

pancreatic cancer

Top articles of Ming Tsao

Title

Journal

Author(s)

Publication Date

Genomic staging of multifocal lung squamous cell carcinomas is independent of the comprehensive morphologic assessment

Journal of Thoracic Oncology

Sanja Dacic

Xuanye Cao

Neus Bota-Rabassedas

Beatriz Sanchez-Espiridion

Sabina Berezowska

...

2024/2/1

Author Correction: The evolutionary history of 2,658 cancers (Nature,(2020), 578, 7793,(122-128), 10.1038/s41586-019-1907-7)

Nature

Moritz Gerstung

Clemency Jolly

Ignaty Leshchiner

Stefan C Dentro

Santiago Gonzalez

...

2023/2/16

CANTRK: a Canadian ring study to optimize detection of NTRK gene fusions by next-generation RNA sequencing

The Journal of Molecular Diagnostics

Tracy L Stockley

Bryan Lo

Adrian Box

Andrea Gomez Corredor

John DeCoteau

...

2023/3/1

Wide‐field Stokes polarimetric microscopy for second harmonic generation imaging

Journal of Biophotonics

Leonardo Uribe Castaño

Kamdin Mirsanaye

Lukas Kontenis

Serguei Krouglov

Edvardas Žurauskas

...

2023/5

Longitudinal plasma ctDNA testing in resected early-stage NSCLC

The Journal of Liquid Biopsy

J Feng

T Waddell

K Yasufuku

A Pierre

A Salvarrey

...

2023/11/1

Historical development of EGFR-targeted therapy

Sebastiao N Martins-Filho

Ming-Sound Tsao

2023/1/1

β-catenin mediates growth defects induced my centrosome loss in APC mutant colorectal cancer independently of p53

bioRxiv

Mohamed Bourmoum

Nikolina Radulovich

Ming-Sound Tsao

Laurence Pelletier

2023/2/16

ctDNA dynamics in early stage node negative lung cancers

Cancer Research

Jamie Feng

Tom Waddell

Kazuhiro Yasufuku

Andrew Pierre

Shaf Keshavjee

...

2023/4/4

Negative Predictive Value of Pre-diagnostic Plasma ctDNA Testing in Patients With Suspected Lung Cancer

The Journal of Liquid Biopsy

M García-Pardo

K Czarnecka-Kujawa

L Le

T Waddell

K Yasufuku

...

2023/11/1

Accelerated hypofractionated radiotherapy for centrally located lung tumours not suitable for stereotactic body radiotherapy or chemoradiotherapy

Clinical Oncology

KL Zeng

I Poon

Y Ung

M Tsao

L Zhang

...

2023/2/1

Single-cell analysis reveals transcriptomic features of drug-tolerant persisters and stromal adaptation in a patient-derived EGFR-mutated lung adenocarcinoma xenograft model

Journal of Thoracic Oncology

Nadeem Moghal

Quan Li

Erin L Stewart

Roya Navab

Masashi Mikubo

...

2023/4/1

P1. 22-04 Plasma-First to Accelerate Time to Treatment and Improve Target Detection in Advanced Lung Cancer: A Prospective Study

Journal of Thoracic Oncology

M Garcia Pardo

K Czarnecka

JH Law

ZJ Fan

TK Waddell

...

2023/11/1

Detection of circular RNAs and their potential as biomarkers predictive of drug response

bioRxiv

Julia Nguyen

Anthony Mammoliti

Sisira Kadambat Nair

Emily So

Farnoosh Abbas-Aghababazadeh

...

2023/1/9

Defining morphologic features of invasion in pulmonary nonmucinous adenocarcinoma with lepidic growth: a proposal by the International Association for the Study of Lung Cancer …

Journal of Thoracic Oncology

Erik Thunnissen

Mary Beth Beasley

Alain Borczuk

Sanja Dacic

Keith M Kerr

...

2023/4/1

International Association for the Study of Lung Cancer study of reproducibility in assessment of pathologic response in resected lung cancers after neoadjuvant therapy

JOURNAL OF THORACIC ONCOLOGY

Mp Smeltzer

Gv Scagliotti

Ha Wakalee

T Mitsudomi

Ub Roy

...

2022

Mitochondrial Aconitase ACO2 Links Iron Homeostasis with Tumorigenicity in Non–Small Cell Lung Cancer

Molecular Cancer Research

Shideh Mirhadi

Wen Zhang

Nhu-An Pham

Fereshteh Karimzadeh

Melania Pintilie

...

2023/1/3

The NRF2 antagonist ML385 inhibits PI3K‐mTOR signaling and growth of lung squamous cell carcinoma cells

Cancer Medicine

Lili Ji

Nadeem Moghal

Xinru Zou

Yixuan Fang

Shuning Hu

...

2023/3

Brief report: canadian cancer trials group IND. 227: A phase 2 randomized study of pembrolizumab in patients with advanced Malignant pleural mesothelioma (NCT02784171)

Journal of Thoracic Oncology

Maria Carmela Piccirillo

Quincy Chu

Penelope Bradbury

Wei Tu

Courtney H Coschi

...

2023/6/1

The 2021 WHO classification of tumors of the pleura: advances since the 2015 classification

Jennifer L Sauter

Sanja Dacic

Francoise Galateau-Salle

Richard L Attanoos

Kelly J Butnor

...

2022/5/1

Therapeutic targeting of hypoxia tolerance and oxygen consumption in pancreatic cancer

Cancer Research

Ji Zhang

Dan Cojocari

Pedro Boasquevisque

Mark Zaidi

Trevor McKee

...

2022/6/15

See List of Professors in Ming Tsao University(University of Toronto)

Ming Tsao FAQs

What is Ming Tsao's h-index at University of Toronto?

The h-index of Ming Tsao has been 89 since 2020 and 146 in total.

What are Ming Tsao's top articles?

The articles with the titles of

Genomic staging of multifocal lung squamous cell carcinomas is independent of the comprehensive morphologic assessment

Author Correction: The evolutionary history of 2,658 cancers (Nature,(2020), 578, 7793,(122-128), 10.1038/s41586-019-1907-7)

CANTRK: a Canadian ring study to optimize detection of NTRK gene fusions by next-generation RNA sequencing

Wide‐field Stokes polarimetric microscopy for second harmonic generation imaging

Longitudinal plasma ctDNA testing in resected early-stage NSCLC

Historical development of EGFR-targeted therapy

β-catenin mediates growth defects induced my centrosome loss in APC mutant colorectal cancer independently of p53

ctDNA dynamics in early stage node negative lung cancers

...

are the top articles of Ming Tsao at University of Toronto.

What are Ming Tsao's research interests?

The research interests of Ming Tsao are: molecular pathology, lung cancer, translational research, pancreatic cancer

What is Ming Tsao's total number of citations?

Ming Tsao has 108,018 citations in total.

What are the co-authors of Ming Tsao?

The co-authors of Ming Tsao are Shaf Keshavjee MD, Paul C. Boutros, TK Waddell, Dongsheng Tu, Toru Furukawa.

Co-Authors

H-index: 99
Shaf Keshavjee MD

Shaf Keshavjee MD

University of Toronto

H-index: 92
Paul C. Boutros

Paul C. Boutros

University of California, Los Angeles

H-index: 89
TK Waddell

TK Waddell

University of Toronto

H-index: 82
Dongsheng Tu

Dongsheng Tu

Queen's University

H-index: 63
Toru Furukawa

Toru Furukawa

Tohoku University

academic-engine